159 related articles for article (PubMed ID: 36481827)
1. Cannabidiol in urine is not a proof of CBD consumption-lesson learned from urine sample analysis in routine caseworks.
Deville M; Charlier C
Forensic Toxicol; 2023 Jul; 41(2):213-220. PubMed ID: 36481827
[TBL] [Abstract][Full Text] [Related]
2. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
[TBL] [Abstract][Full Text] [Related]
3. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.
Casati S; Angeli I; Bergamaschi RF; Ravelli A; Colombo G; Binelli G; Minoli M; Orioli M
Forensic Sci Int; 2022 Apr; 333():111237. PubMed ID: 35228140
[TBL] [Abstract][Full Text] [Related]
4. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use.
Mareck U; Fusshöller G; Geyer H; Huestis MA; Scheiff AB; Thevis M
Drug Test Anal; 2021 Mar; 13(3):539-549. PubMed ID: 33125823
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
[TBL] [Abstract][Full Text] [Related]
6. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A
J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613
[TBL] [Abstract][Full Text] [Related]
7. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
Pacifici R; Pichini S; Pellegrini M; Tittarelli R; Pantano F; Mannocchi G; Rotolo MC; Busardò FP
Clin Chem Lab Med; 2018 Dec; 57(2):238-243. PubMed ID: 30332386
[TBL] [Abstract][Full Text] [Related]
8. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".
Hädener M; Gelmi TJ; Martin-Fabritius M; Weinmann W; Pfäffli M
Int J Legal Med; 2019 May; 133(3):821-832. PubMed ID: 30612324
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.
Swift W; Wong A; Li KM; Arnold JC; McGregor IS
PLoS One; 2013; 8(7):e70052. PubMed ID: 23894589
[TBL] [Abstract][Full Text] [Related]
11. Potency of Δ
Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M
Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730
[TBL] [Abstract][Full Text] [Related]
12. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
13. Validation of an UHPLC/DAD method for the determination of cannabinoids in seized materials: Analysis of 213 samples sold in Belgian CBD shops.
Deville M; Dubois N; Denooz R; Charlier C
Forensic Sci Int; 2020 May; 310():110234. PubMed ID: 32200307
[TBL] [Abstract][Full Text] [Related]
14. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis.
Hart ED; Vikingsson S; Mitchell JM; Winecker RE; Flegel R; Hayes ED
J Anal Toxicol; 2022 May; 46(5):573-576. PubMed ID: 33987675
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
16. Mid-infrared spectroscopy as process analytical technology tool for estimation of THC and CBD content in Cannabis flowers and extracts.
Geskovski N; Stefkov G; Gigopulu O; Stefov S; Huck CW; Makreski P
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119422. PubMed ID: 33477086
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
18. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair.
Hill VA; Schaffer MI; Paulsen RB; Stowe GN
J Anal Toxicol; 2022 May; 46(5):487-493. PubMed ID: 34153110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
